These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 18826102)
41. Bortezomib sensitizes human head and neck carcinoma cells SQ20B to radiation. Weber CN; Cerniglia GJ; Maity A; Gupta AK Cancer Biol Ther; 2007 Feb; 6(2):156-9. PubMed ID: 17224644 [TBL] [Abstract][Full Text] [Related]
42. Enhanced radio sensitivity with iodinated contrast agents using monochromatic synchrotron X-rays on human cancerous cells. Estève F; Corde S; Elleaume H; Adam JF; Joubert A; Charvet AM; Biston MC; Balosso J; Le Bas JF Acad Radiol; 2002 Aug; 9 Suppl 2():S540-3. PubMed ID: 12188332 [No Abstract] [Full Text] [Related]
43. Normal tissue reactions in mice after combined treatment with metoclopramide and ionizing radiation. Lybak S; Kjellén E; Nilsson P; Tomaszewicz A; Wennerberg J; Pero RW Acta Oncol; 1992; 31(4):469-74. PubMed ID: 1632984 [TBL] [Abstract][Full Text] [Related]
44. Photodynamic activity on human larynx epidermoid carcinoma cell line, HEp-2. Ganesan S; Masilamani V Med Oncol; 1994; 11(3-4):139-41. PubMed ID: 7543350 [No Abstract] [Full Text] [Related]
45. Comparative ultrastructure analysis of radiation-induced radioresistant laryngeal cancer hep-2 cell line. Yang B; Tang F; Zhang B; Zhao Y; Ding S; Rao Z Ultrastruct Pathol; 2014 Aug; 38(4):285-9. PubMed ID: 24684578 [TBL] [Abstract][Full Text] [Related]
46. Novel approach for bladder cancer treatment using sulfoquinovosylacylpropanediol as a radiosensitizer. Yagisawa T; Okumi M; Omoto K; Sawada Y; Morikawa S; Tanabe K Int J Urol; 2016 Mar; 23(3):270-2. PubMed ID: 26690732 [No Abstract] [Full Text] [Related]
47. Elusive goal of targeting tumor hypoxia for therapeutic gain. Peters L; Rischin D J Clin Oncol; 2012 May; 30(15):1741-3. PubMed ID: 22508811 [No Abstract] [Full Text] [Related]
48. Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo. Milross CG; Mason KA; Hunter NR; Terry NH; Patel N; Harada S; Jibu T; Seong J; Milas L Eur J Cancer; 1997 Jul; 33(8):1299-308. PubMed ID: 9301459 [TBL] [Abstract][Full Text] [Related]
49. Effect of combination of curcumin and GLUT-1 AS-ODN on radiosensitivity of laryngeal carcinoma through regulating autophagy. Dai LB; Yu Q; Zhou SH; Bao YY; Zhong JT; Shen LF; Lu ZJ; Fan J; Huang YP Head Neck; 2020 Sep; 42(9):2287-2297. PubMed ID: 32314842 [TBL] [Abstract][Full Text] [Related]
50. [Clinical value of NSD and CRE in the evaluation of risk of post-irradiation complications in patients with laryngeal cancer]. Maciejewski B Nowotwory; 1982; 32(3):153-63. PubMed ID: 7155911 [No Abstract] [Full Text] [Related]
52. Letter: On the mechanism of sensitization of living cells towards ionizing radiation by oxygen and other sensitizers. van Hemmen JJ; Meuling WJ; van der Schans GP; Bleichrodt JF Int J Radiat Biol Relat Stud Phys Chem Med; 1974 Apr; 25(4):399-402. PubMed ID: 4599691 [No Abstract] [Full Text] [Related]
53. Sirolimus as a potential radiosensitizer in squamous cell cancer of the head and neck. Shinohara ET; Maity A; Jha N; Lustig RA Head Neck; 2009 Mar; 31(3):406-11. PubMed ID: 18704962 [TBL] [Abstract][Full Text] [Related]
54. Investigation of the tumourigenicity of Wi-38 and Hep-2 cells in ALS-treated white mice. Stones PB; Ackerley ET; Meade P Prog Immunobiol Stand; 1971; 5():193-7. PubMed ID: 4660534 [No Abstract] [Full Text] [Related]
55. In reply to Franken and Barendsen. Lawrence YR; Dicker AP; Ohri N Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):598-9. PubMed ID: 23773388 [No Abstract] [Full Text] [Related]
56. In regard to Ohri N et al. Franken NA; Barendsen GW Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):598. PubMed ID: 23773387 [No Abstract] [Full Text] [Related]
57. [Radioresistance and targeted radiosensitization of laryngeal carcinoma]. Luo Y; Bao Y; Zhou S Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun; 49(6):520-4. PubMed ID: 25241878 [No Abstract] [Full Text] [Related]